June 2020, Volume 6, Issue 7

June 2020

Volume 6, Issue 7

This issue explores COVID-19-associated coagulopathy, how to model professionalism in communication, and more.

Table of Contents

June 2020 Issue

Editor’s Corner: We Will Fly Again!

Monday, June 1st, 2020
Travel has always been an important part of medicine, as the need to connect with colleagues in person to collaborate and learn from each...
You Make the Call

Reader Responses: How would you treat these patients with acute stroke who are positive...

Monday, June 1st, 2020
Here’s how readers responded to a You Make the Call question about anticoagulation for patients with antiphospholipid antibodies and a history of stroke. Disclaimer: ASH...

June 2020 Issue

WIB_icon

Predicting Survival in MM With Renal Impairment and Light Chain Cast Nephropathy

Monday, June 1st, 2020
The quality of renal response to therapy was associated with survival in patients with multiple myeloma (MM) with renal impairment and light chain cast...
WIB_icon

BTKi Improves Disease Control in CLL After Progression on Venetoclax

Monday, June 1st, 2020
Treatment with a Bruton tyrosine kinase inhibitor (BTKi) showed efficacy in patients with relapsed/refractory chronic lymphocytic leukemia (CLL) that progressed on venetoclax, according to...
WIB_icon

Is NCCN-IPI a Better Prognostic Tool for DLBCL Treated With R-CHOP?

Monday, June 1st, 2020
Compared with the widely used International Prognostic Index (IPI) and revised IPI (R-IPI), the most recent National Comprehensive Cancer Network IPI (NCCN-IPI) better predicts...
ASH Directions

ASH Hosts Webinar on Treating COVID-19 With Convalescent Plasma, and more

Monday, June 1st, 2020
On May 12, the American Society of Hematology (ASH) hosted a webinar on the use of convalescent plasma (i.e., plasma from patients who have...

Abnormal Coagulation Parameters Associated With Mortality in Severe Coronavirus Pneumonia

Monday, June 1st, 2020
Disseminated intravascular coagulation (DIC), marked by elevated D-dimer and fibrin degradation products (FDP), is associated with a higher risk of mortality in patients with...
WIB_icon

Ruxolitinib Improves Outcomes in Patients With Steroid-Refractory Graft-Versus-Host Disease

Monday, June 1st, 2020
Patients with steroid-refractory acute graft-versus-host disease (GVHD) following hematopoietic cell transplant (HCT) experienced durable clinical responses by 28 days and had promising overall survival...
The Society Pages

Marc J. Kahn Named Dean of UNLV School of Medicine, ASH Members Are Finalists...

Monday, June 1st, 2020
Marc J. Kahn Named Dean of UNLV School of Medicine Marc J. Kahn, MD, has been appointed the dean of the School of Medicine at...

Tisagenlecleucel Improves Patient-Reported Quality of Life in Relapsed/Refractory DLBCL

Monday, June 1st, 2020
Treatment with tisagenlecleucel was associated with clinically meaningful improvements in health-related quality of life (QoL) over 18 months in patients with diffuse large B-cell...

FDA Grants CC-486 (Oral Azacitidine) Priority Review for AML Maintenance

Monday, June 1st, 2020
The FDA granted priority review status to CC-486 for maintenance treatment of adult patients with acute myeloid leukemia (AML) who achieved complete remission (CR)...

UGT1A1*28 Genotype Is Associated With Reduced Overall Survival in Intermediate-Risk AML

Monday, June 1st, 2020
Patients with intermediate-risk acute myeloid leukemia (AML) who are treated with cytarabine-based chemotherapy have lower overall survival (OS) if they possess the low-activity UGT1A1*28...

June 2020 Issue

Coagulation Dysregulation

Monday, June 1st, 2020
Thrombosis is a major contributor to death in patients with severe coronavirus infection. As new data emerge, experts discuss approaches to prevention and treatment. In...

Pulling Back the Curtain: Richard Aster, MD, and Jon Aster, MD, PhD

Monday, June 1st, 2020
In this edition, Richard “Dick” Aster, MD, and his son, Jon Aster, MD, PhD, talk about their shared interests in research and golf. Dick, where did...

A Hematologist Pumps Iron: Shernan Holtan, MD

Monday, June 1st, 2020
In this edition of pASHions, Shernan Holtan, MD, spreads the word about powerlifting – a sport she says physicians and patients can benefit from. Can...

FAQs From Oncologists

Monday, June 1st, 2020
In this first edition of HemOnc Link, Gerald Soff, MD, sheds light on some of the most common questions that hematologists are asked by...

June 2020 Issue

How I Teach Professionalism With Ariela Marshall, MD

Monday, June 1st, 2020
Ariela Marshall, MD, talks about modeling professional communication for trainees by respecting patients’ and colleagues’ differences in gender identity, culture, ethnicity, sexual orientation, and...
You Make the Call

You Make the Call: How would you treat these patients with acute stroke who...

Monday, June 1st, 2020
This month Keith R. McCrae, MD, discusses anticoagulation for patients with antiphospholipid antibodies and a history of stroke. And don't forget to check out next month's...

June 2020 Issue